TIAA CREF Investment Management’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	$179K	Buy	+317	New	+$179K	﹤0.01%	2903
2018 Q4	–	Sell	-259	Closed	-$184K	–	3030
2018 Q3	$184K	Buy	+259	New	+$184K	﹤0.01%	2998
2018 Q2	–	Sell	-165	Closed	-$448K	–	3120
2018 Q1	$448K	Buy	+165	New	+$448K	﹤0.01%	2787